Conversely, elevated Sp1 O-GlcNAcylation levels exacerbate mitochondrial dysfunction and contribute to pathological cardiac hypertrophy and myocardial fibrosis in patients with diabetic cardiomyopathy. This evidence concerns the gene SP1 and diabetic cardiomyopathy.